Skip to main content

Table 8 Results for GPC5, rs10492503. Corrected P values using the Benjimini-Hochberg (PBH) and Bonferroni (PBon) methods are presented below the uncorrected P value

From: An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population

 

GPC5

rs10492503

Polymorphism

Genotypes

 

Alleles

Group

AA (%)

AT (%)

TT (%)

p

(PBH, PBon)

HWE

A (%)

T (%)

P

OR (95% CI)

MS total cases (n= 204)

67 (32.8)

98 (48.1)

39 (19.1)

0.016

(0.08, 0.128)

0.767

232 (56.8)

176 (43.2)

0.0079

1.50

PP case (n= 53)

24 (45.3)

24 (45.3)

5 (9.4)

0.492

 

72 (67.9)

34 (32.1)

0.781

0.94

SP case (n= 51)

13 (25.5)

31 (60.8)

7 (13.7)

0.0098

 

57 (55.9)

45 (44.1)

0.0519

1.56

RR case (n= 100)

30 (30)

43 (43)

27 (27)

0.0067

 

103 (52.5)

97 (48.5)

0.0006

1.87

Male (n= 44)

14 (31.8)

21 (47.7)

9 (20.5)

0.560

 

49 (55.7)

39 (44.3)

0.299

1.42

Female (n= 160)

53 (33.1)

77 (48.1)

30 (18.8)

0.0286

 

183 (57.2)

137 (42.8)

0.0148

1.52

Control (n= 164)

78 (47.6)

62 (37.8)

24 (14.6)

 

0.052

218 (66.5)

110 (33.5)

  

HapMap CEU (%)

38.3

51.7

10

  

64.2

35.8

 Â